Identification of novel molecular prognostic markers for paediatric T-cell acute lymphoblastic leukaemia

British Journal of Haematology

Volumn 137, Issue 4, 2007, Pages 319-328

  Gottardo, Nicholas G ^a,b   Hoffmann, Katrin ^a   Beesley, Alex H ^a   Freitas, Joseph R ^a   Firth, Martin J ^a   Perera, Kanchana U ^a   De Klerk, Nicolas H ^a   Baker, David L ^b   Kees, Ursula R ^a,c  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b PRINCESS MARGARET HOSPITAL FOR CHILDREN   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Children; Gene expression; Microarray; Prognosis; T cell acute lymphoblastic leukaemia

Indexed keywords

BTG FAMILY MEMBER 3 PROTEIN; FLICE INHIBITORY PROTEIN; MOLECULAR MARKER; NOTCH2 RECEPTOR; PROTEIN; UNCLASSIFIED DRUG;

ACCURACY; ACUTE LYMPHOBLASTIC LEUKEMIA; APOPTOSIS; ARTICLE; CANCER DIAGNOSIS; CANCER RELAPSE; CANCER SURVIVAL; CELL CYCLE REGULATION; CELL PROLIFERATION; CHILD; CHILDHOOD LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; FEMALE; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE IDENTIFICATION; HUMAN; HUMAN TISSUE; INCIDENCE; MALE; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T CELL LEUKEMIA;

ADOLESCENT; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CHILD; CHILD, PRESCHOOL; FEMALE; GENE EXPRESSION PROFILING; GENETIC MARKERS; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; LEUKEMIA, T-CELL, ACUTE; MALE; MULTIVARIATE ANALYSIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROTEINS; RECEPTOR, NOTCH2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SURVIVAL RATE;

EID: 34247484097     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2007.06576.x     Document Type: Article

References (38)

1. Artavanis-Tsakonas, S., Rand, M.D. Lake, R.J. (1999) Notch signaling: cell fate control and signal integration in development. Science, 284, 770 776 (Review).
2. Ballerini, P., Blaise, A., Busson-Le Coniat, M., Su, X.Y., Zucman-Rossi, J., Adam, M., van den Akker, J., Perot, C., Pellegrino, B., Landman-Parker, J., Berger, R. Bernard, O.A. (2002) HOX11L2 expression defines a clinical subtype of paediatric T-ALL associated with poor prognosis. Blood, 100, 991 997.
3. Beesley, A.H., Cummings, A.J., Freitas, J.R., Hoffmann, K., Firth, M.J., Ford, J., de Klerk, N.H. Kees, U.R. (2005) The gene expression signature of relapse in paediatric acute lymphoblastic leukaemia: implications for mechanisms of therapy failure. British Journal of Haematology, 131, 447 456.
4. Boatright, K.M., Deis, C., Denault, J.B., Sutherlin, D.P. Salvesen, G.S. (2004) Activation of caspases-8 and -10 by FLIP(L). Biochemical Journal, 382, 651 657.
5. Breit, S., Stanulla, M., Flohr, T., Schrappe, M., Ludwig, W.D., Tolle, G., Happich, M., Muckenthaler, M.U. Kulozik, A.E. (2006) Activating NOTCH1 mutations predict favourable early treatment response and long-term outcome in childhood precursor T-cell lymphoblastic leukaemia. Blood, 108, 1151 1157.
6. Cairo, G., Stanulla, M., Fine, B.M., Teuffel, O., Neuhoff, N.V., Schrauder, A., Flohr, T., Schafer, B.W., Bartram, C.R., Welte, K., Schlegelberger, B. Schrappe, M. (2005) Distinct gene expression profiles determine molecular treatment response in childhood acute lymphoblastic leukaemia. Blood, 105, 821 826.
7. Cavé H., Suciu, S., Preudhomme, C., Poppe, B., Robert, A., Uyttebroeck, A., Malet, M., Boutard, P., Benoit, Y., Mauvieux, L., Lutz, P., Méchinaud, F., Grardel, N., Mazingue, F., Dupont, M., Margueritte, G., Pages, M.-P., Bertrand, Y., Plouvier, E., Brunie, G., Bastard, C., Plantaz, D., Vande Velde, I., Hagemeijer, A., Speleman, F., Lessard, M., Otten, J., Vilmer, E. Dastugue, N. for the EORTC-CLG (2004) Clinical significance of HOX11L2 expression linked to t(5:14)(q35:q32), of HOX11 expression, and of SIL-TAL fusion in childhood T-cell malignancies: results of EORTC studies 58 881 and 58 951. Blood, 103, 442 450.
8. Chang, D.W., Xing, Z., Pan, Y., Algeciras-Schimnich, A., Barnhart, B.C., Yaish-Ohad, S., Peter, M.E. Yang, X. (2002) c-FLIP(L) is a dual function regulator for caspase-8 activation and CD95-mediated apoptosis. The EMBO Journal, 21, 3704 3714.
9. Chiaretti, S., Li, X., Gentleman, R., Vitale, A., Vignetti, M., Mandelli, F., Ritz, J. Foa, R. (2004) Gene expression profile of adult T-cell acute lymphocytic leukaemia identifies distinct subsets of patients with different response to therapy and survival. Blood, 103, 2771 2778.
10. Dallas, P.B., Gottardo, N.G., Firth, M.J., Beesley, A.H., Hoffmann, K., Terry, P.A., Freitas, J.R., Boag, J.M., Cummings, A.J. Kees, U.R. (2005) Gene expression levels assessed by oligonucleotide microarray analysis and quantitative real-time RT-PCR - how well do they correlate BMC Genomics, 6, 59 ().
11. Einsiedel, H.G., von Stackelberg, A., Hartmann, R., Fengler, R., Schrappe, M., Janka-Schaub, G., Mann, G., Hahlen, K., Gobel, U., Klingebiel, T., Ludwig, W.D. Henze, G. (2005) Long-term outcome in children with relapsed ALL by risk-stratified salvage therapy: results of trial acute lymphoblastic leukaemia-relapse study of the Berlin-Frankfurt-Munster Group 87. Journal of Clinical Oncology, 23, 7942 7950.
12. Ferrando, A.A., Neuberg, D.S., Staunton, J., Loh, M.L., Huard, C., Raimondi, S.C., Behm, F.G., Pui, C.H., Downing, J.R., Gilliland, D.G., Lander, E.S., Golub, T.R. Look, T.L. (2002) Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukaemia. Cancer Cell, 1, 75 87.
13. Ferrando, A.A., Neuberg, D.S., Dodge, R.K., Paietta, E., Larson, R.A., Wiernik, P.H., Rowe, J.M., Caligiuri, M.A., Bloomfeld, C.D. Look, T.L. (2004) Prognostic importance of TLX1 (HOX11) oncogene expression in adults with T-cell acute lymphoblastic leukaemia. Lancet, 363, 535 536.
14. Gaynon, P.S., Trigg, M.E., Heerema, N.A., Sensel, M.G., Sather, H.N., Hammond, G.D. Bleyer, W.A. (2000) Children's Cancer Group trials in childhood acute lymphoblastic leukaemia: 1983-1995. Leukaemia, 14, 2223 2233.
15. Goldberg, J.M., Silverman, L.B., Levy, D.E., Dalton, V.K., Gelber, R.D., Lehmann, L., Cohen, H.J., Sallan, S.E. Asselin, B.L. (2003) Childhood T-cell acute lymphoblastic leukaemia: the Dana-Farber Cancer Institute acute lymphoblastic leukaemia consortium experience. Journal of Clinical Oncology, 21, 3616 3622.
16. Gottardo, N.G., Jacoby, P.A., Sather, H.N., Reaman, G.H., Baker, D.L. Kees, U.R. (2005) Significance of HOX11L2/TLX3 expression in children with T-cell acute lymphoblastic leukaemia treated on Children's Cancer Group protocols. Leukaemia, 19, 1705 1708.
17. Heerema, N.A., Sather, H.N., Sensel, M.G., Kraft, P., Nachman, J.B., Steinherz, P.G., Lange, B.J., Hutchinson, R.S., Reaman, G.H., Trigg, M.E., Arthur, D.C., Gaynon, P.S. Uckun, F.M. (1998) Frequency and clinical significance of cytogenetic abnormalities in paediatric T-lineage acute lymphoblastic leukaemia: a report from the Children's Cancer Group. Journal of Clinical Oncology, 16, 1270 1278.
18. Hoffmann, K., Firth, M.J., Freitas, J.R., de Klerk, N.H. Kees, U.R. (2005) Gene expression levels in small specimens from patients detected using oligonucleotide arrays. Molecular Biotechnology, 29, 31 38.
19. Hoffmann, K., Firth, M.J., Beesley, A.H., de Klerk, N.H. Kees, U.R. (2006) Translating microarray data for diagnostic testing in childhood leukaemia. BMC Cancer, 6, 229.
20. Holleman, A., den Boer, M.L., Cheok, M.H., Kazemier, K.M., Pei, D., Downing, J.R., Janka-Schaub, G.E., Gobel, U., Graubner, U.B., Pui, C.H., Evans, W.E. Pieters, R. (2006a) Expression of the outcome predictor in acute leukaemia 1 (OPAL1) gene is not an independent prognostic factor in patients treated according to COALL or St Jude protocols. Blood, 108, 1984 1990.
21. Holleman, A., den Boer, M.L., de Menezes, R.X., Cheok, M.H., Cheng, C., Kazemier, K.M., Janka-Schaub, G.E., Gobel, U., Graubner, U.B., Evans, W.E. Pieters, R. (2006b) The expression of 70 apoptosis genes in relation to lineage, genetic subtype, cellular drug resistance, and outcome in childhood acute lymphoblastic leukaemia. Blood, 107, 769 776.
22. Kawamura-Tsuzuku, J., Suzuki, T., Yoshida, Y. Yamamoto, T. (2004) Nuclear localization of Tob is important for regulation of its antiproliferative activity. Oncogene, 23, 6630 6638.
23. Kees, U.R., Heerema, N.A., Kumar, R., Watt, P.M., Baker, D.L., La, M.K., Uckun, F.M. Sather, H.N. (2003) Expression of HOX11 in childhood T-lineage acute lymphoblastic leukaemia can occur in the absence of cytogenetic aberration at 10q24: a study from the Children's Cancer Group (CCG). Leukaemia, 17, 887 893.
24. Kordes, U., Krappmann, D., Heissmeyer, V., Ludwig, W.D. Scheidereit, C. (2000) Transcription factor NF-kappaB is constitutively activated in acute lymphoblastic leukaemia cells. Leukaemia, 3, 399 402.
25. Lugthart, S., Cheok, M.H., den Boer, M.L., Yang, W., Holleman, A., Cheng, C., Pui, C.H., Relling, M.V., Janka-Schaub, G.E., Pieters, R. Evans, W.E. (2005) Identification of genes associated with chemotherapy crossresistance and treatment response in childhood acute lymphoblastic leukaemia. Cancer Cell, 7, 375 386.
26. Matsuda, S., Rouault, J., Magaud, J. Berthet, C. (2001) In search of a function for the TIS21/PC3/BTG1/TOB family. FEBS Letters, 497, 67 72 (Review).
27. Mosquera-Caro, M., Helman, P., Veroff, R., Shuster, J., Martin, S., Davidson, G., Potter, J., Harvey, R., Hromas, R., Andries, E., Atlas, S., Wilson, C., Ar, K., Xu, Y., Chen, I.M., Carroll, A., Camitta, B. Willman, C. (2003) Identification, validation and cloning of a novel gene (OPAL1) and associated genes highly predictive of outcome in paediatric acute lymphoblastic leukaemia using gene expression profiling [abstract]. Blood, 102, 4a.
28. Nachman, J.B., Sather, H.N., Sensel, M.G., Trigg, M.E., Cherlow, J.M., Lukens, J.N., Wolff, L., Uckun, F.M. Gaynon, P.S. (1998) Augmented post-induction therapy for children with high-risk acute lymphoblastic leukaemia and a slow response to initial therapy. New England Journal of Medicine, 338, 1663 1671.
29. Parr, C., Watkins, G. Jiang, W.G. (2004) The possible correlation of Notch-1 and Notch-2 with clinical outcome and tumour clinicopathological parameters in human breast cancer. International Journal of Molecular Medicine, 5, 779 786.
30. Pear, W.S. Aster, J.C. (2004) T cell acute lymphoblastic leukemia/lymphoma: a human cancer commonly associated with aberrant NOTCH1 signaling. Current Opinion in Hematology, 11, 426 433 (Review).
31. Pui, C.H. Evans, W.E. (2006) Treatment of acute lymphoblastic leukaemia. New England Journal of Medicine, 354, 166 178 (Review).
32. Pullen, J., Shuster, J.J., Link, M., Borowitz, M., Amylon, M., Carroll, A.J., Land, V., Look, A.T., McIntyre, B. Camitta, B. (1999) Significance of commonly used prognostic factors differs for children with T cell acute lymphocytic leukaemia (ALL), as compared to those with B-precursor ALL. A Paediatric Oncology Group (POG) study. Leukaemia, 11, 1696 1707.
33. Seibel, N.L., Asselin, B.L., Nachman, J.B., Steinherz, P., Camitta, B., Devidas, M. Sather, H.N. (2004) Treatment of high risk T-cell acute lymphoblastic leukemia (T-ALL): comparison of recent experience of the Children's Cancer Group (CCG) and Pediatric Oncology Group (POG) [abstract]. Blood, 104, 681.
34. Sherlock, G. (2005) Of fish and chips. Nature Methods, 2, 329 330.
35. Valente, G., Manfroi, F., Peracchio, C., Nicotra, G., Castino, R., Nicosia, G., Kerim, S. Isidoro, C. (2006) cFLIP expression correlates with tumour progression and patient outcome in non-Hodgkin lymphomas of low grade of malignancy. British Journal of Haematology, 132, 560 570.
36. Valnet-Rabier, M.B., Challier, B., Thiebault, S., Angonin, R., Margueritte, G., Mougin, C., Kantelip, B., Deconinck, E., Cahn, J.Y. Fest, T. (2005) c-Flip protein expression in Burkitt's lymphomas is associated with a poor clinical outcome. British Journal of Haematology, 128, 767 773.
37. Weng, A.P., Ferrando, A.A., Lee, W., Morris 4th., J.P., Silverman, L.B., Sanchez-Irizarry, C., Blacklow, S.C., Look, A.T. Aster, J.C. (2004) Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukaemia. Science, 306, 269 271.
38. Yeoh, E.J., Ross, M.E., Shurtleff, S.A., Williams, W.K., Patel, D., Mahfouz, R., Behm, F.G., Raimondi, S.C., Relling, M.V., Patel, A., Cheng, C., Campana, D., Wilkins, D., Zhou, X., Li, J., Liu, H., Pui, C.H., Evans, W.E., Naeve, C., Wong, L. Downing, J.R. (2002) Classification, subtype discovery, and prediction of outcome in paediatric acute lymphoblastic leukaemia by gene expression profiling. Cancer Cell, 1, 133 143.